Agilent 23 févr. 2026 FDA Approval Deepens Agilent Role In KEYTRUDA Ovarian Cancer Testing - simplywall.st
Agilent 23 févr. 2026 Agilent Technologies (A) Stock Analysis: A Promising 38% Upside In The Healthcare Sector - DirectorsTalk Interviews
Agilent 20 févr. 2026 Stay Ahead of the Game With Agilent (A) Q1 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
Agilent 20 févr. 2026 Stay Ahead of the Game With Agilent (A) Q1 Earnings: Wall Street's Insights on Key Metrics - Nasdaq
Agilent 13 févr. 2026 Agilent Receives FDA Approval for Companion Diagnostic in Ovarian Cancer - Femtech Insider
Agilent 12 févr. 2026 Agilent Technologies, Inc. (NYSE:A) to Issue $0.26 Quarterly Dividend - MarketBeat
Agilent 12 févr. 2026 Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval - Fierce Biotech
Agilent 11 févr. 2026 Agilent Technologies (A) Declares $0.255 Quarterly Dividend; 0.8% Yield - StreetInsider
Agilent 11 févr. 2026 Own Agilent stock by March 31? A $0.255 cash payout is coming in April - Stock Titan
Agilent 11 févr. 2026 Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - BioSpace
Agilent 11 févr. 2026 Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - Business Wire